CA2217388A1 - Composition de tyrosine et d'allergene polymerise - Google Patents

Composition de tyrosine et d'allergene polymerise Download PDF

Info

Publication number
CA2217388A1
CA2217388A1 CA002217388A CA2217388A CA2217388A1 CA 2217388 A1 CA2217388 A1 CA 2217388A1 CA 002217388 A CA002217388 A CA 002217388A CA 2217388 A CA2217388 A CA 2217388A CA 2217388 A1 CA2217388 A1 CA 2217388A1
Authority
CA
Canada
Prior art keywords
allergen
tyrosine
solution
polymerised
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002217388A
Other languages
English (en)
Inventor
Alan Worland Wheeler
Iain Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergy Therapeutics UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2217388A1 publication Critical patent/CA2217388A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composition pharmaceutique comportant de la tyrosine et un allergène polymérisé, préparée (a) par polymérisation d'un allergène, (b) par mélange d'une solution aqueuse dudit allergène avec une solution de tyrosine dans un acide aqueux fort, (c) par neutralisation du mélange de solutions, ce qui entraîne une co-précipitation de la tyrosine et de l'allergène polymérisé, et (d) par mélange éventuel du produit avec un excipient physiologiquement acceptable.
CA002217388A 1995-04-29 1996-04-25 Composition de tyrosine et d'allergene polymerise Abandoned CA2217388A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9508785.4 1995-04-29
GBGB9508785.4A GB9508785D0 (en) 1995-04-29 1995-04-29 Novel compositions

Publications (1)

Publication Number Publication Date
CA2217388A1 true CA2217388A1 (fr) 1996-11-07

Family

ID=10773769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002217388A Abandoned CA2217388A1 (fr) 1995-04-29 1996-04-25 Composition de tyrosine et d'allergene polymerise

Country Status (20)

Country Link
EP (1) EP0825874A1 (fr)
JP (1) JPH11504338A (fr)
KR (1) KR19990008120A (fr)
CN (1) CN1132629C (fr)
AU (1) AU705873B2 (fr)
BG (1) BG63990B1 (fr)
BR (1) BR9608123A (fr)
CA (1) CA2217388A1 (fr)
CZ (1) CZ288401B6 (fr)
EA (1) EA199700271A1 (fr)
GB (1) GB9508785D0 (fr)
HK (1) HK1010834A1 (fr)
HU (1) HUP9802237A3 (fr)
NO (1) NO974893L (fr)
NZ (1) NZ308080A (fr)
PL (1) PL183484B1 (fr)
SK (1) SK281877B6 (fr)
TR (1) TR199701265T1 (fr)
WO (1) WO1996034626A1 (fr)
ZA (1) ZA963340B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
GB201106802D0 (en) * 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377074A (en) * 1971-07-13 1974-12-11 Beecham Group Ltd Process for preparing injectable compositions
US4070455A (en) * 1974-02-16 1978-01-24 Beecham Group Limited Process for preparing injectable desensitizing compositions and products thereof in microparticle form
EP0058021A3 (fr) * 1981-02-06 1982-10-27 Beecham Group Plc Compositions pharmaceutiques
ES2013359A6 (es) * 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.

Also Published As

Publication number Publication date
CN1132629C (zh) 2003-12-31
PL323104A1 (en) 1998-03-16
JPH11504338A (ja) 1999-04-20
AU705873B2 (en) 1999-06-03
BG63990B1 (bg) 2003-09-30
CZ288401B6 (en) 2001-06-13
BG102004A (en) 1998-11-30
CZ342997A3 (cs) 1998-03-18
PL183484B1 (pl) 2002-06-28
NZ308080A (en) 1999-05-28
NO974893D0 (no) 1997-10-23
HUP9802237A2 (hu) 1999-02-01
TR199701265T1 (xx) 1998-02-21
KR19990008120A (ko) 1999-01-25
HK1010834A1 (en) 1999-07-02
CN1183046A (zh) 1998-05-27
AU5761696A (en) 1996-11-21
SK146197A3 (en) 1998-05-06
SK281877B6 (sk) 2001-08-06
GB9508785D0 (en) 1995-06-21
NO974893L (no) 1997-10-23
EA199700271A1 (ru) 1998-04-30
WO1996034626A1 (fr) 1996-11-07
ZA963340B (en) 1997-03-27
HUP9802237A3 (en) 2000-06-28
EP0825874A1 (fr) 1998-03-04
BR9608123A (pt) 1999-02-09

Similar Documents

Publication Publication Date Title
EP0018561B1 (fr) Procédé pour la stabilisation des facteurs de coagulation du sang
DE602005004014T2 (de) Verfahren zur solubilisierung von peptid-mischungen
JPH09509183A (ja) フィブリノーゲン、xiii因子及びフィブロネクチンを含んで成る生物学的接着剤の獲得方法
CA2126685A1 (fr) Methode de preparation de microcapsules
US4070455A (en) Process for preparing injectable desensitizing compositions and products thereof in microparticle form
EP2293776B1 (fr) Fibrinogen étant fontionellement intact, stable au stockage et inactivé de virus
EP0271885B1 (fr) Médicament contenant la protéine tissulaire PP4, procédé de préparation de PP4 et sa pasteurisation et l'utilisation de PP4
AU705873B2 (en) Composition of tyrosine and polymerised allergen
CA2035948A1 (fr) Polysaccharides ayant des proprietes immunomodulantes tires de astragalus membranaceus et compositions pharmaceutqiues en contenant
US8105605B2 (en) Allergen formulation
AU727822B2 (en) Compositions useful as fibrin sealants
MXPA97008336A (en) Composition of tyrosine and allergen polymerize
JPH02138130A (ja) 重合されたアレルゲンの製造方法
US5936256A (en) Method of preparing a biological material for use in ophthalmology
JPS5822444B2 (ja) ヘンセイアレルゲンオユウスルチロシンノ セイゾウホウ
CA2107516C (fr) Preparation d'antithrombine iii
SU1165406A1 (ru) Способ получени альбумина
WO2022079678A1 (fr) Procédé de production de nanomatériaux biocompatibles à capacités de reconnaissance sélective et leurs utilisations
CN1323088C (zh) 一种破伤风免疫球蛋白的生产方法
JPH04306236A (ja) 保存安定性に優れた絹フィブロイン水溶液及びその製造法
JPH05170655A (ja) ウイルス不活化剤およびウイルスの不活化方法
EP0238986A2 (fr) Procédé de préparation d'une composition contenant le facteur VIII de coagulation sanguine, sous une forme concentrée

Legal Events

Date Code Title Description
FZDE Discontinued